CIK 0001692415
- Non-accelerated filer
- Smaller reporting company
Co-Diagnostics, Inc.
Sign in to watch- Ticker
- CODX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- UT
- Entity type
- Operating
- EIN
- 462609396
- Phone
- +1 801-438-1036
- Business address
- 2401 S FOOTHILL DRIVE, SUITE D, SALT LAKE CITY, UT, 84109
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-01 | Reagents, LLC Former 10% Owner | Other disposition | −25,000 | $192,505.00 | $4.8B | 1,746,796 |
| 2020-02-10 | SERBIN RICHARD S Director | Grant or award · Non-Qualified Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2020-02-10 | Durenard Eugene Director | Grant or award · Non-Qualified Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2019-09-03 | Egan Dwight H Chief Executive Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2019-09-03 | BENSON REED L CFO & Secretary | Grant or award · Non-Qualified Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2019-06-25 | Durenard Eugene Director | Grant or award · Non-Qualified Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2019-04-24 | SERBIN RICHARD S Director | Grant or award · Non-Qualified Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2018-12-06 | America 2030 Capital, LLC 10% owner | Returned to the company | −1,134,898 | $0.01 | $11K | 0 |
| 2018-10-05 | Egan Dwight H Chief Executive Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2018-10-05 | BENSON REED L Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2018-07-18 | America 2030 Capital, LLC 10% owner | Returned to the company | −1,134,897 | $0.01 | $11K | 1,134,898 |
| 2018-05-11 | Satterfield Brent Chief Science Officer | Purchase | +1,305 | $1.82 | $2K | 2,275,000 |
| 2018-05-03 | Satterfield Brent Chief Science Officer | Purchase | +500 | $1.91 | $955 | 2,273,695 |
| 2018-04-23 | Satterfield Brent Chief Science Officer | Purchase | +500 | $2.02 | $1K | 2,273,198 |
| 2018-04-16 | Satterfield Brent Chief Science Officer | Purchase | +500 | $1.94 | $970 | 2,272,698 |
| 2018-04-09 | Satterfield Brent Chief Science Officer | Purchase | +2,400 | $2.05 | $5K | 2,272,198 |
| 2018-04-09 | Satterfield Brent Chief Science Officer | Purchase | +2,400 | $4,920.00 | $11.8M | 2,272,198 |
| 2017-12-13 | BENSON REED L CFO and Secretary | Returned to the company | −2,776 | $4.65 | $13K | 17,792 |
| 2017-12-13 | BENSON REED L CFO and Secretary | Returned to the company | −17,792 | $4.65 | $83K | 0 |
| 2017-09-19 | Reagents, LLC Former 10% Owner | Other disposition | −181,817 | 1,771,796 |
Page 14 of 14 · 280 trades